Literature DB >> 24781216

Interictal scalp electroencephalography and intraoperative electrocorticography in magnetic resonance imaging-negative temporal lobe epilepsy surgery.

David B Burkholder1, Vlastimil Sulc2, E Matthew Hoffman1, Gregory D Cascino1, Jeffrey W Britton1, Elson L So1, W Richard Marsh3, Fredric B Meyer3, Jamie J Van Gompel3, Caterina Giannini4, C Thomas Wass5, Robert E Watson6, Gregory A Worrell7.   

Abstract

IMPORTANCE: Scalp electroencephalography (EEG) and intraoperative electrocorticography (ECoG) are routinely used in the evaluation of magnetic resonance imaging-negative temporal lobe epilepsy (TLE) undergoing standard anterior temporal lobectomy with amygdalohippocampectomy (ATL), but the utility of interictal epileptiform discharge (IED) identification and its role in outcome are poorly defined.
OBJECTIVES: To determine whether the following are associated with surgical outcomes in patients with magnetic resonance imaging-negative TLE who underwent standard ATL: (1) unilateral-only IEDs on preoperative scalp EEG; (2) complete resection of tissue generating IEDs on ECoG; (3) complete resection of opioid-induced IEDs recorded on ECoG; and (4) location of IEDs recorded on ECoG. DESIGN, SETTING, AND PARTICIPANTS: Data were gathered through retrospective medical record review at a tertiary referral center. Adult and pediatric patients with TLE who underwent standard ATL between January 1, 1990, and October 15, 2010, were considered for inclusion. Inclusion criteria were magnetic resonance imaging-negative TLE, standard ECoG performed at the time of surgery, and a minimum follow-up of 12 months. Univariate analysis was performed using log-rank time-to-event analysis. Variables reaching significance with log-rank testing were further analyzed using Cox proportional hazards. MAIN OUTCOMES AND MEASURES: Excellent or nonexcellent outcome at time of last follow-up. An excellent outcome was defined as Engel class I and a nonexcellent outcome as Engel classes II through IV.
RESULTS: Eighty-seven patients met inclusion criteria, with 48 (55%) achieving an excellent outcome following ATL. Unilateral IEDs on scalp EEG (P = .001) and complete resection of brain regions generating IEDs on baseline intraoperative ECoG (P = .02) were associated with excellent outcomes in univariate analysis. Both were associated with excellent outcomes when analyzed with Cox proportional hazards (unilateral-only IEDs, relative risk = 0.31 [95% CI, 0.16-0.64]; complete resection of IEDs on baseline ECoG, relative risk = 0.39 [95% CI, 0.20-0.76]). Overall, 25 of 35 patients (71%) with both unilateral-only IEDs and complete resection of baseline ECoG IEDs had an excellent outcome. CONCLUSIONS AND RELEVANCE: Unilateral-only IEDs on preoperative scalp EEG and complete resection of IEDs on baseline ECoG are associated with better outcomes following standard ATL in magnetic resonance imaging-negative TLE. Prospective evaluation is needed to clarify the use of ECoG in tailoring temporal lobectomy.

Entities:  

Mesh:

Year:  2014        PMID: 24781216      PMCID: PMC4183227          DOI: 10.1001/jamaneurol.2014.585

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  35 in total

1.  The lateralizing and surgical prognostic value of a single 2-hour EEG in mesial TLE.

Authors:  S K Lee; K K Kim; K S Hong; J Y Kim; C K Chung
Journal:  Seizure       Date:  2000-07       Impact factor: 3.184

2.  Factors predicting outcome of surgery for intractable epilepsy with pathologically verified mesial temporal sclerosis.

Authors:  Steven G Hardy; John W Miller; Mark D Holmes; Donald E Born; George A Ojemann; Carl B Dodrill; Danial K Hallam
Journal:  Epilepsia       Date:  2003-04       Impact factor: 5.864

3.  Alfentanil-induced epileptiform activity: a simultaneous surface and depth electroencephalographic study in complex partial epilepsy.

Authors:  J Ross; L A Kearse; M K Barlow; K J Houghton; G R Cosgrove
Journal:  Epilepsia       Date:  2001-02       Impact factor: 5.864

4.  Opioid peptides may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons.

Authors:  W Zieglgänsberger; E D French; G R Siggins; F E Bloom
Journal:  Science       Date:  1979-07-27       Impact factor: 47.728

5.  The effects of remifentanil on epileptiform discharges during intraoperative electrocorticography in patients undergoing epilepsy surgery.

Authors:  C T Wass; R E Grady; A J Fessler; G D Cascino; L Lozada; P S Bechtle; W R Marsh; F W Sharbrough; D R Schroeder
Journal:  Epilepsia       Date:  2001-10       Impact factor: 5.864

6.  Intraoperative hippocampal electrocorticography to predict the extent of hippocampal resection in temporal lobe epilepsy surgery.

Authors:  G M McKhann; J Schoenfeld-McNeill; D E Born; M M Haglund; G A Ojemann
Journal:  J Neurosurg       Date:  2000-07       Impact factor: 5.115

7.  The predictive value of intraoperative electrocorticography in resections for limbic epilepsy associated with mesial temporal sclerosis.

Authors:  T H Schwartz; C W Bazil; T S Walczak; S Chan; T A Pedley; R R Goodman
Journal:  Neurosurgery       Date:  1997-02       Impact factor: 4.654

8.  Activation of electrocorticographic activity with remifentanil and alfentanil during neurosurgical excision of epileptogenic focus.

Authors:  G McGuire; H El-Beheiry; P Manninen; A Lozano; R Wennberg
Journal:  Br J Anaesth       Date:  2003-11       Impact factor: 9.166

Review 9.  Preoperative evaluation for temporal lobe surgery.

Authors:  Christine Kilpatrick; Terence O'Brien; Zelko Matkovic; Mark Cook; Andrew Kaye
Journal:  J Clin Neurosci       Date:  2003-09       Impact factor: 1.961

10.  Seizure outcome after anterior temporal lobectomy and its predictors in patients with apparent temporal lobe epilepsy and normal MRI.

Authors:  P N Sylaja; K Radhakrishnan; C Kesavadas; P S Sarma
Journal:  Epilepsia       Date:  2004-07       Impact factor: 5.864

View more
  7 in total

1.  Integrating artificial intelligence with real-time intracranial EEG monitoring to automate interictal identification of seizure onset zones in focal epilepsy.

Authors:  Yogatheesan Varatharajah; Brent Berry; Jan Cimbalnik; Vaclav Kremen; Jamie Van Gompel; Matt Stead; Benjamin Brinkmann; Ravishankar Iyer; Gregory Worrell
Journal:  J Neural Eng       Date:  2018-06-01       Impact factor: 5.379

2.  Preoperative prediction of temporal lobe epilepsy surgery outcome.

Authors:  Daniel M Goldenholz; Alexander Jow; Omar I Khan; Anto Bagić; Susumu Sato; Sungyoung Auh; Conrad Kufta; Sara Inati; William H Theodore
Journal:  Epilepsy Res       Date:  2016-09-22       Impact factor: 3.045

Review 3.  Interictal high-frequency oscillations in focal human epilepsy.

Authors:  Jan Cimbalnik; Michal T Kucewicz; Greg Worrell
Journal:  Curr Opin Neurol       Date:  2016-04       Impact factor: 5.710

Review 4.  Surgical strategies for pediatric epilepsy.

Authors:  Jian Guan; Michael Karsy; Katrina Ducis; Robert J Bollo
Journal:  Transl Pediatr       Date:  2016-04

5.  Quantitative analysis of visually reviewed normal scalp EEG predicts seizure freedom following anterior temporal lobectomy.

Authors:  Yogatheesan Varatharajah; Boney Joseph; Benjamin Brinkmann; Marcia Morita-Sherman; Zachary Fitzgerald; Deborah Vegh; Dileep Nair; Richard Burgess; Fernando Cendes; Lara Jehi; Gregory Worrell
Journal:  Epilepsia       Date:  2022-04-22       Impact factor: 6.740

6.  Surgical Outcomes and EEG Prognostic Factors After Stereotactic Laser Amygdalohippocampectomy for Mesial Temporal Lobe Epilepsy.

Authors:  Shasha Wu; Naoum P Issa; Maureen Lacy; David Satzer; Sandra L Rose; Carina W Yang; John M Collins; Xi Liu; Taixin Sun; Vernon L Towle; Douglas R Nordli; Peter C Warnke; James X Tao
Journal:  Front Neurol       Date:  2021-05-17       Impact factor: 4.003

7.  Detection of Epileptic Seizures Using Phase-Amplitude Coupling in Intracranial Electroencephalography.

Authors:  Kohtaroh Edakawa; Takufumi Yanagisawa; Haruhiko Kishima; Ryohei Fukuma; Satoru Oshino; Hui Ming Khoo; Maki Kobayashi; Masataka Tanaka; Toshiki Yoshimine
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.